In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.

2013

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

25

References

4

Citations